These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17701606)

  • 1. Multiple myeloma and renal cell carcinoma possible association.
    Badros A; Karakunnel J; Dawson N
    Leuk Lymphoma; 2007 Aug; 48(8):1662-4. PubMed ID: 17701606
    [No Abstract]   [Full Text] [Related]  

  • 2. Fine-needle aspiration biopsy of multiple myeloma in a patient with renal-cell carcinoma: a case report.
    Cooper GL; Shaffer DW; Raval HB
    Diagn Cytopathol; 1993 Oct; 9(5):551-4. PubMed ID: 8287765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of multiple myeloma and clear cell renal cell carcinoma: a case report and review of literature.
    Xu G; Yang M; Huang J; Jin J
    Int J Clin Exp Pathol; 2015; 8(6):7627-30. PubMed ID: 26261682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute promyelocytic leukaemia complicating multiple myeloma: evidence of different cell lineages.
    Dunkley S; Gibson J; Iland H; Li C; Joshua D
    Leuk Lymphoma; 1999 Nov; 35(5-6):623-6. PubMed ID: 10609802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation.
    Oka S; Ono K; Nohgawa M
    Ann Hematol; 2017 Aug; 96(8):1411-1413. PubMed ID: 28577044
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Klatte T
    Eur Urol; 2015 Oct; 68(4):737. PubMed ID: 26334120
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Laguna MP
    J Urol; 2015 May; 193(5):1514-5. PubMed ID: 25895755
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
    Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
    Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast carcinoma metastasis into a renal cell carcinoma].
    Perrin C; Talarmin M; Fontaine A; Kerbrat P; Audrain O; Rioux-Leclercq N; Chiforeanu DC
    Ann Pathol; 2011 Oct; 31(5):399-401. PubMed ID: 21982250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
    Srinivasan S; Schiffer CA
    Leuk Res; 2009 Apr; 33(4):561-4. PubMed ID: 18676017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous presentation and following remission of chronic lymphocytic leukemia and multiple myeloma.
    Bernardeschi P; Bonechi I; Marchetti G; Puglisi R
    Recenti Prog Med; 1995 Jan; 86(1):25. PubMed ID: 7709037
    [No Abstract]   [Full Text] [Related]  

  • 12. Reconciling the use of cytoreductive nephrectomy in the targeted therapy era.
    Culp SH
    Eur Urol; 2014 Oct; 66(4):711-2. PubMed ID: 25001889
    [No Abstract]   [Full Text] [Related]  

  • 13. Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report.
    Sher T; Miller KC; Lee K; Chanan-Khan A
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):328-30. PubMed ID: 19717386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloma and thymoma: an as yet unreported association.
    Sichère P; Galimard E; Fromaget M; Donskoff C
    Rev Rhum Engl Ed; 1997; 64(7-9):518-9. PubMed ID: 9338938
    [No Abstract]   [Full Text] [Related]  

  • 15. Bortezomib Does Not Prevent the Occurrence of Kaposi's Sarcoma in Patients with Haematological Malignancies: Two Case Reports.
    Chavarot N; Lebbe C; Thervet E; Bouscary D; Karras A
    Acta Derm Venereol; 2017 Oct; 97(9):1138-1139. PubMed ID: 28597021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma.
    Sakai A; Kawano M; Kuramoto A
    N Engl J Med; 1991 Jun; 324(26):1893-4. PubMed ID: 2041555
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple melanoma-progress in understanding of molecular mechanism and improvement in treatment outcome with introduction of new drugs for multiple myeloma].
    Hanamura I; Iida S
    Gan To Kagaku Ryoho; 2010 May; 37(5):816-21. PubMed ID: 20524255
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment.
    Szturz P; Adam Z; Vašků V; Feit J; Krejčí M; Pour L; Hájek R; Mayer J
    Leuk Lymphoma; 2013 Jun; 54(6):1324-6. PubMed ID: 23061634
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumores rari et inusitati. Development of multiple myeloma in long term survivors of breast cancer.
    Yeh GK; Axelrod MR
    Clin Oncol; 1979 Jun; 5(2):175-7. PubMed ID: 223792
    [No Abstract]   [Full Text] [Related]  

  • 20. An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications.
    Choueiri TK; Baz RC; McFadden CM; Khasawneh M; Karam MA; Kelly M; Hussein MA
    BJU Int; 2008 Mar; 101(6):712-5. PubMed ID: 17970789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.